Shubhadeep Sinha
Head Global and Vice-President,
Clinical Science Lead (Senior Manager)
HETERO
India
Biography
Dr Shubhadeep Sinha is a senior pharmaceutical physician with over 17 years of experience in Global Clinical Development, Pharmacovigilance, Medical Affairs in Pharmaceuticals & CROs. He is Currently Vice-President and Head- global clinical, medical and pharmacovigilance operations at Hetero group of pharmaceuticals. He is highly experienced in setting up, expanding and operating teams in clinical development, global pharmacovigilance, medical affairs in Pharmaceuticals including Dr. Reddy’s, Hetero, Glenmark, Organon & CROs including Vimta Labs, Alquest LLC. He has also managed end to end clinical development of multiple biosimilars including Darbepoetin, Rituximab, Bevacizumab, Adalimumab and currently ongoing Trastuzumab and a few others at Hetero including domestic and international development & registration.
Research Interest
Darbepoetin, Rituximab, Bevacizumab, Adalimumab and currently ongoing Trastuzumab
